A new initiative has been launched in the UAE to support low-income expatriates battling cancer and multiple sclerosis.
They will be provided with medication as part of the Ministry of Health and Prevention's (MOHAP) new agreement with the pharmaceutical firm Merck Serono, and Manzil Healthcare Services.
The programme will benefit patients diagnosed with colorectal, head and neck, and urothelial cancer, as well as multiple sclerosis.
It aims to support those who don't have medical insurance and those with partial coverage.
"The initiative is one of a series of memoranda of understanding signed by the ministry to improve the services provided to low-income patients and secure their access to high-quality medicines," said Dr. Amin Hussein Al Amiri, Assistant Undersecretary for the Health Regulation Sector at MOHAP.
"It will help doctors follow the best practices in the treatment plan, and enable patients to follow up and complete their treatment plan," he added.


UAE President to begin state visit to Germany on Wednesday
UAE flights to Jakarta face disruptions due to volcanic ash
UAE launches programme to empower Emirati youth address water challenges
H.H. Sheikh Mohammed pays tribute to UAE President in new book
Falcon sets world auction record at AED2.1 million in Abu Dhabi
UAE expresses solidarity with Greece over death of two pilots in plane crash
UAE joins 7 other countries in rejecting displacement of Palestinians from Gaza
Five UAE aid convoys enter Gaza carrying 533 tonnes of supplies
